GeNeuro S.A.
GNRO.PA · PAR
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | €146 | €147 | €145 | €144 |
| Gross Profit | -€146 | -€147 | -€145 | -€144 |
| % Margin | – | – | – | – |
| R&D Expenses | €6,226 | €5,942 | €5,100 | €4,576 |
| G&A Expenses | €1,241 | €2 | €2 | €1 |
| SG&A Expenses | €1,286 | €1,693 | €1,681 | €1,397 |
| Sales & Mktg Exp. | €45 | €1,691 | €1,680 | €1,396 |
| Other Operating Expenses | €60 | €1 | -€8 | €21 |
| Operating Expenses | €7,572 | €7,635 | €6,773 | €5,994 |
| Operating Income | -€7,580 | -€7,782 | -€6,917 | -€6,138 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -€599 | €653 | €47 | -€506 |
| Pre-Tax Income | -€8,180 | -€7,129 | -€6,871 | -€6,644 |
| Tax Expense | -€285 | -€267 | -€346 | -€968 |
| Net Income | -€8 | -€6,862 | -€6,524 | -€5,675 |
| % Margin | – | – | – | – |
| EPS | -0.32 | -0.28 | -0.26 | -0.25 |
| % Growth | -14.3% | -7.7% | -4% | – |
| EPS Diluted | -0.32 | -0.28 | -0.26 | -0.25 |
| Weighted Avg Shares Out | 24,835 | 24,852 | 24,841 | 22,932 |
| Weighted Avg Shares Out Dil | 24,835 | 24,852 | 24,841 | 22,932 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €567 | €386 | €156 | €113 |
| Depreciation & Amortization | €146 | €147 | €145 | €144 |
| EBITDA | -€7,466 | -€6,596 | -€6,570 | -€6,386 |
| % Margin | – | – | – | – |